This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.—
Shortly before publication in the Archives of our article titled "Neuroparalytic Accidents of Antirabies Vaccination With Suckling Mouse Brain (SMB) Rabies Vaccine" (34:694-700, 1977), we had the opportunity to study a new fatal case of Guillain-Barre syndrome.
Report of a Case.—
A 71-year-old man received seven subcutaneous doses of SMB rabies vaccine for postexposure prophylaxis. The symptoms appeared six days after termination of the vaccination and the clinical picture was characterized by facial diplegia, bulbar muscle involvement, and descending quadriplegia with generalized areflexia. Cerebrospinal fluid values were normal with a slight increase of the IgG level (0.72 mg/dl). The patient was treated with high doses of corticoids and required respiratory assistance from the second day of evolution. Two weeks after the onset of the symptoms, the patient died suddenly. Autopsy was not performed. Virological studies of the vaccine batch were done with negative results. Encephalitogenic activity of
Vergara I, Toro G, Román G, Mendoza G. Fatal Guillain-Barre Syndrome With Reduced-dose Antirabies Vaccination. Arch Neurol. 1979;36(4):254. doi:10.1001/archneur.1979.00500400108026
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: